Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,635 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HMGB1: A new marker for estimation of the postmortem interval.
Kikuchi K, Kawahara KI, Biswas KK, Ito T, Tancharoen S, Shiomi N, Koda Y, Matsuda F, Morimoto Y, Oyama Y, Takenouchi K, Miura N, Arimura N, Nawa Y, Arimura S, Jie MX, Shrestha B, Iwata M, Mera K, Sameshima H, Ohno Y, Maenosono R, Tajima Y, Uchikado H, Kuramoto T, Nakayama K, Shigemori M, Yoshida Y, Hashiguchi T, Maruyama I. Kikuchi K, et al. Among authors: ohno y. Exp Ther Med. 2010 Jan;1(1):109-111. doi: 10.3892/etm_00000019. Epub 2010 Jan 1. Exp Ther Med. 2010. PMID: 23136602 Free PMC article.
Minocycline attenuates both OGD-induced HMGB1 release and HMGB1-induced cell death in ischemic neuronal injury in PC12 cells.
Kikuchi K, Kawahara K, Biswas KK, Ito T, Tancharoen S, Morimoto Y, Matsuda F, Oyama Y, Takenouchi K, Miura N, Arimura N, Nawa Y, Meng X, Shrestha B, Arimura S, Iwata M, Mera K, Sameshima H, Ohno Y, Maenosono R, Yoshida Y, Tajima Y, Uchikado H, Kuramoto T, Nakayama K, Shigemori M, Hashiguchi T, Maruyama I. Kikuchi K, et al. Among authors: ohno y. Biochem Biophys Res Commun. 2009 Jul 24;385(2):132-6. doi: 10.1016/j.bbrc.2009.04.041. Epub 2009 Apr 18. Biochem Biophys Res Commun. 2009. PMID: 19379716
Potential of edaravone for neuroprotection in neurologic diseases that do not involve cerebral infarction.
Kikuchi K, Kawahara KI, Uchikado H, Miyagi N, Kuramoto T, Miyagi T, Morimoto Y, Ito T, Tancharoen S, Miura N, Takenouchi K, Oyama Y, Shrestha B, Matsuda F, Yoshida Y, Arimura S, Mera K, Tada KI, Yoshinaga N, Maenosono R, Ohno Y, Hashiguchi T, Maruyama I, Shigemori M. Kikuchi K, et al. Among authors: ohno y. Exp Ther Med. 2011 Sep;2(5):771-775. doi: 10.3892/etm.2011.281. Epub 2011 Jun 7. Exp Ther Med. 2011. PMID: 22977573 Free PMC article.
Edaravone attenuates cerebral ischemic injury by suppressing aquaporin-4.
Kikuchi K, Tancharoen S, Matsuda F, Biswas KK, Ito T, Morimoto Y, Oyama Y, Takenouchi K, Miura N, Arimura N, Nawa Y, Meng X, Shrestha B, Arimura S, Iwata M, Mera K, Sameshima H, Ohno Y, Maenosono R, Tajima Y, Uchikado H, Kuramoto T, Nakayama K, Shigemori M, Yoshida Y, Hashiguchi T, Maruyama I, Kawahara K. Kikuchi K, et al. Among authors: ohno y. Biochem Biophys Res Commun. 2009 Dec 25;390(4):1121-5. doi: 10.1016/j.bbrc.2009.09.015. Epub 2009 Sep 6. Biochem Biophys Res Commun. 2009. PMID: 19737535
Edaravone: a new therapeutic approach for the treatment of acute stroke.
Kikuchi K, Kawahara K, Miyagi N, Uchikado H, Kuramoto T, Morimoto Y, Tancharoen S, Miura N, Takenouchi K, Oyama Y, Shrestha B, Matsuda F, Yoshida Y, Arimura S, Mera K, Tada K, Yoshinaga N, Maenosono R, Ohno Y, Hashiguchi T, Maruyama I, Shigemori M. Kikuchi K, et al. Among authors: ohno y. Med Hypotheses. 2010 Dec;75(6):583-5. doi: 10.1016/j.mehy.2010.07.038. Epub 2010 Aug 21. Med Hypotheses. 2010. PMID: 20728280
Chest Magnetic Resonance Imaging: Advances and Clinical Care.
Ozawa Y, Nagata H, Ueda T, Oshima Y, Hamabuchi N, Yoshikawa T, Takenaka D, Ohno Y. Ozawa Y, et al. Among authors: ohno y. Clin Chest Med. 2024 Jun;45(2):505-529. doi: 10.1016/j.ccm.2024.02.017. Epub 2024 Mar 23. Clin Chest Med. 2024. PMID: 38816103 Review.
C-Reactive Protein-Albumin Ratio Predicts Objective Response to Enfortumab Vedotin in Metastatic Urothelial Carcinoma.
Uchimoto T, Matsuda T, Komura K, Fukuokaya W, Adachi T, Hirasawa Y, Hashimoto T, Yoshizawa A, Saruta M, Hashimoto M, Higashio T, Tsuchida S, Nishimura K, Tsujino T, Nakamura K, Fukushima T, Nishio K, Yamamoto S, Iwatani K, Urabe F, Mori K, Yanagisawa T, Tsuduki S, Takahara K, Inamoto T, Miki J, Fujita K, Kimura T, Ohno Y, Shiroki R, Uemura H, Azuma H. Uchimoto T, et al. Among authors: ohno y. Target Oncol. 2024 May 28. doi: 10.1007/s11523-024-01068-7. Online ahead of print. Target Oncol. 2024. PMID: 38807017
Size of Self-Expandable Transcatheter Heart Valve and Mid-Term Adverse Events After Transcatheter Aortic Valve Replacement.
Hioki H, Yamamoto M, Watanabe Y, Ohno Y, Yashima F, Naganuma T, Tada N, Shirai S, Yamanaka F, Mizutani K, Noguchi M, Izumo M, Takagi K, Asami M, Ueno H, Nishina H, Otsuka T, Hayashida K; OCEAN-TAVI investigators. Hioki H, et al. Among authors: ohno y. Am J Cardiol. 2024 May 24:S0002-9149(24)00371-0. doi: 10.1016/j.amjcard.2024.05.018. Online ahead of print. Am J Cardiol. 2024. PMID: 38797196
Comparative Data of Procedural and Midterm Outcomes in Patients Who Underwent Percutaneous Left Atrial Appendage Closure Between the WATCHMAN FLX and WATCHMAN 2.5 Devices　- Insight From the OCEAN-LAAC Registry.
Nakashima M, Yamamoto M, Sago M, Tanaka S, Chatani R, Asami M, Hachinohe D, Naganuma T, Ohno Y, Tani T, Okamatsu H, Mizutani K, Watanabe Y, Izumo M, Saji M, Mizuno S, Ueno H, Kubo S, Shirai S, Hayashida K; OCEAN-LAAC Investigators. Nakashima M, et al. Among authors: ohno y. Circ J. 2024 May 17. doi: 10.1253/circj.CJ-24-0062. Online ahead of print. Circ J. 2024. PMID: 38763735 Free article.
2,635 results